{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T13:15:48Z","timestamp":1792329348796,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Data obtained recently in the United Kingdom following a nationwide infant immunization program against serogroup B <jats:italic>Neisseria meningitidis<\/jats:italic> (MenB) reported &gt;80% 4CMenB vaccine-mediated protection. Factor H-binding protein (fHbp) is a meningococcal virulence factor and a component of two new MenB vaccines. Here, we investigated the structural bases underlying the fHbp-dependent protective antibody response in humans, which might inform future antigen design efforts. We present the co-crystal structure of a human antibody Fab targeting fHbp. The vaccine-elicited Fab 1A12 is cross-reactive and targets an epitope highly conserved across the repertoire of three naturally occurring fHbp variants. The free Fab structure highlights conformational rearrangements occurring upon antigen binding. Importantly, 1A12 is bactericidal against MenB strains expressing fHbp from all three variants. Our results reveal important immunological features potentially contributing to the broad protection conferred by fHbp vaccination. Our studies fuel the rationale of presenting conserved protein epitopes when developing broadly protective vaccines.<\/jats:p>","DOI":"10.1038\/s41467-018-02827-7","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T21:39:03Z","timestamp":1517434743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp"],"prefix":"10.1038","volume":"9","author":[{"given":"Jacinto","family":"L\u00f3pez-Sagaseta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-083X","authenticated-orcid":false,"given":"Peter T.","family":"Beernink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-3788","authenticated-orcid":false,"given":"Elisabetta","family":"Frigimelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Bottomley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"2827_CR1","doi-asserted-by":"publisher","first-page":"20502","DOI":"10.1074\/jbc.M701634200","volume":"282","author":"TS Fisher","year":"2007","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe 2010. (Stockholm, ECDC, 2010).","journal-title":"J. Biol. Chem."},{"key":"2827_CR2","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.cmi.2016.03.006","volume":"22","author":"M Sadarangani","year":"2016","unstructured":"Sadarangani, M. & Pollard, A. J. Can we control all-cause meningococcal disease in Europe? Clin. Microbiol. Infect. 22 Suppl 5, S103\u2013S112 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"2827_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","author":"V Masignani","year":"2003","unstructured":"Masignani, V. et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197, 789\u2013799 (2003).","journal-title":"J. Exp. Med."},{"key":"2827_CR4","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"LD Fletcher","year":"2004","unstructured":"Fletcher, L. D. et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect. Immun. 72, 2088\u20132100 (2004).","journal-title":"Infect. Immun."},{"key":"2827_CR5","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","volume":"28","author":"HQ Jiang","year":"2010","unstructured":"Jiang, H. Q. et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28, 6086\u20136093 (2010).","journal-title":"Vaccine"},{"key":"2827_CR6","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1016\/j.vaccine.2011.04.095","volume":"29","author":"O Koeberling","year":"2011","unstructured":"Koeberling, O. et al. Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys. Vaccine 29, 4728\u20134734 (2011).","journal-title":"Vaccine"},{"key":"2827_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/656741","volume":"51","author":"J Findlow","year":"2010","unstructured":"Findlow, J. et al. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51, 1127\u20131137 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"2827_CR8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/INF.0b013e31826327e4","volume":"31","author":"HS Marshall","year":"2012","unstructured":"Marshall, H. S. et al. Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial. Pediatr. Infect. Dis. J. 31, 1061\u20131068 (2012).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2827_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.vaccine.2013.01.021","volume":"31","author":"HS Marshall","year":"2013","unstructured":"Marshall, H. S. et al. A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine 31, 1569\u20131575 (2013).","journal-title":"Vaccine"},{"key":"2827_CR10","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/S0140-6736(16)32061-X","volume":"388","author":"NE Basta","year":"2016","unstructured":"Basta, N. E. & Christensen, H. 4CMenB vaccine effectiveness: reasons for optimism. Lancet 388, 2719\u20132721 (2016).","journal-title":"Lancet"},{"key":"2827_CR11","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","volume":"388","author":"SR Parikh","year":"2016","unstructured":"Parikh, S. R. et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet 388, 2775\u20132782 (2016).","journal-title":"Lancet"},{"key":"2827_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","volume":"177","author":"G Madico","year":"2006","unstructured":"Madico, G. et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 177, 501\u2013510 (2006).","journal-title":"J. Immunol."},{"key":"2827_CR13","doi-asserted-by":"publisher","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","volume":"5","author":"I Costa","year":"2014","unstructured":"Costa, I., Pajon, R. & Granoff, D. M. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio 5, e01625\u201314 (2014).","journal-title":"MBio"},{"key":"2827_CR14","doi-asserted-by":"publisher","first-page":"e88907","DOI":"10.1172\/jci.insight.88907","volume":"1","author":"DM Granoff","year":"2016","unstructured":"Granoff, D. M. et al. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight 1, e88907 (2016).","journal-title":"JCI Insight"},{"key":"2827_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/infdis\/jiv081","volume":"212","author":"DM Granoff","year":"2015","unstructured":"Granoff, D. M. et al. Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine. J. Infect. Dis. 212, 784\u2013792 (2015).","journal-title":"J. Infect. Dis."},{"key":"2827_CR16","doi-asserted-by":"publisher","first-page":"e00842","DOI":"10.1128\/mBio.00842-15","volume":"6","author":"PT Beernink","year":"2015","unstructured":"Beernink, P. T., Giuntini, S., Costa, I., Lucas, A. H. & Granoff, D. M. Functional analysis of the human antibody response to meningococcal factor H binding protein. MBio 6, e00842 (2015).","journal-title":"MBio"},{"key":"2827_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","volume":"73","author":"MM Giuliani","year":"2005","unstructured":"Giuliani, M. M. et al. The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect. Immun. 73, 1151\u20131160 (2005).","journal-title":"Infect. Immun."},{"key":"2827_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jmb.2008.12.005","volume":"386","author":"M Scarselli","year":"2009","unstructured":"Scarselli, M. et al. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis. J. Mol. Biol. 386, 97\u2013108 (2009).","journal-title":"J. Mol. Biol."},{"key":"2827_CR19","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1128\/IAI.00367-08","volume":"76","author":"PT Beernink","year":"2008","unstructured":"Beernink, P. T. et al. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein. Infect. Immun. 76, 4232\u20134240 (2008).","journal-title":"Infect. Immun."},{"key":"2827_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.molimm.2009.02.021","volume":"46","author":"PT Beernink","year":"2009","unstructured":"Beernink, P. T., LoPasso, C., Angiolillo, A., Felici, F. & Granoff, D. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol. Immunol. 46, 1647\u20131653 (2009).","journal-title":"Mol. Immunol."},{"key":"2827_CR21","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1096\/fj.13-239012","volume":"28","author":"A Faleri","year":"2014","unstructured":"Faleri, A. et al. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties. FASEB J. 28, 1644\u20131653 (2014).","journal-title":"FASEB J."},{"key":"2827_CR22","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1074\/jbc.M808831200","volume":"284","author":"A Mascioni","year":"2009","unstructured":"Mascioni, A. et al. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J. Biol. Chem. 284, 8738\u20138746 (2009).","journal-title":"J. Biol. Chem."},{"key":"2827_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep00341","volume":"2","author":"DM Vu","year":"2012","unstructured":"Vu, D. M., Pajon, R., Reason, D. C. & Granoff, D. M. A broadly cross-reactive monoclonal antibody against an epitope on the N-terminus of meningococcal fHbp. Sci. Rep. 2, 341 (2012).","journal-title":"Sci. Rep."},{"key":"2827_CR24","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1073\/pnas.1222845110","volume":"110","author":"E Malito","year":"2013","unstructured":"Malito, E. et al. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc. Natl Acad. Sci. USA 110, 3304\u20133309 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2827_CR25","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1042\/BCJ20160806","volume":"473","author":"E Malito","year":"2016","unstructured":"Malito, E. et al. Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergy. Biochem. J. 473, 4699\u20134713 (2016).","journal-title":"Biochem. J."},{"key":"2827_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/BCJ20160996","volume":"474","author":"EH Klontz","year":"2017","unstructured":"Klontz, E. H. & Sundberg, E. J. Getting oriented with antibodies. Biochem. J. 474, 517\u2013519 (2017).","journal-title":"Biochem. J."},{"key":"2827_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/jmbi.1999.3144","volume":"293","author":"JP Derrick","year":"1999","unstructured":"Derrick, J. P., Maiden, M. C. & Feavers, I. M. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain. J. Mol. Biol. 293, 81\u201391 (1999).","journal-title":"J. Mol. Biol."},{"key":"2827_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jmb.2005.06.061","volume":"351","author":"CJ Oomen","year":"2005","unstructured":"Oomen, C. J. et al. Crystal structure of an anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design. J. Mol. Biol. 351, 1070\u20131080 (2005).","journal-title":"J. Mol. Biol."},{"key":"2827_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1097-0134(199709)29:1<113::AID-PROT9>3.0.CO;2-G","volume":"29","author":"JM van den Elsen","year":"1997","unstructured":"van den Elsen, J. M. et al. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide. Proteins 29, 113\u2013125 (1997).","journal-title":"Proteins"},{"key":"2827_CR30","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","volume":"27","author":"LK McNeil","year":"2009","unstructured":"McNeil, L. K. et al. Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide. Vaccine 27, 3417\u20133421 (2009).","journal-title":"Vaccine"},{"key":"2827_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-595","volume":"11","author":"KA Jolley","year":"2010","unstructured":"Jolley, K. A. & Maiden, M. C. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11, 595 (2010).","journal-title":"BMC Bioinformatics"},{"key":"2827_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4939-2763-0_10","volume":"1320","author":"K Diederichs","year":"2016","unstructured":"Diederichs, K. Crystallographic data and model quality. Methods Mol. Biol. 1320, 147\u2013173 (2016).","journal-title":"Methods Mol. Biol."},{"key":"2827_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.str.2015.10.028","volume":"24","author":"CA MacRaild","year":"2016","unstructured":"MacRaild, C. A., Richards, J. S., Anders, R. F. & Norton, R. S. Antibody recognition of disordered antigens. Structure 24, 148\u2013157 (2016).","journal-title":"Structure"},{"key":"2827_CR34","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.molimm.2007.10.016","volume":"45","author":"ND Rubinstein","year":"2008","unstructured":"Rubinstein, N. D. et al. Computational characterization of B-cell epitopes. Mol. Immunol. 45, 3477\u20133489 (2008).","journal-title":"Mol. Immunol."},{"key":"2827_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","volume":"458","author":"MC Schneider","year":"2009","unstructured":"Schneider, M. C. et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890\u2013893 (2009).","journal-title":"Nature"},{"key":"2827_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S1744309111006154","volume":"67","author":"L Cendron","year":"2011","unstructured":"Cendron, L., Veggi, D., Girardi, E. & Zanotti, G. Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086). Acta Crystallogr. F Struct. Biol. Cryst. Commun. 67, 531\u2013535 (2011).","journal-title":"Acta Crystallogr. F Struct. Biol. Cryst. Commun."},{"key":"2827_CR37","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1073\/pnas.1521142113","volume":"113","author":"M Biagini","year":"2016","unstructured":"Biagini, M. et al. Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined. Proc. Natl Acad. Sci. USA 113, 2714\u20132719 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2827_CR38","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","volume":"69","author":"R Borrow","year":"2001","unstructured":"Borrow, R., Andrews, N., Goldblatt, D. & Miller, E. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect. Immun. 69, 1568\u20131573 (2001).","journal-title":"Infect. Immun."},{"key":"2827_CR39","doi-asserted-by":"publisher","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","volume":"27","author":"CE Frasch","year":"2009","unstructured":"Frasch, C. E., Borrow, R. & Donnelly, J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine 27 Suppl 2, B112\u2013B116 (2009).","journal-title":"Vaccine"},{"key":"2827_CR40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1586\/14760584.2015.1071670","volume":"14","author":"JT Poolman","year":"2015","unstructured":"Poolman, J. T. & Richmond, P. Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness. Expert Rev. Vaccines 14, 1277\u20131287 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"2827_CR41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","volume":"6","author":"I Delany","year":"2014","unstructured":"Delany, I., Rappuoli, R. & De Gregorio, E. Vaccines for the 21st century. EMBO Mol. Med. 6, 708\u2013720 (2014).","journal-title":"EMBO Mol. Med."},{"key":"2827_CR42","doi-asserted-by":"publisher","first-page":"156241","DOI":"10.1155\/2015\/156241","volume":"2015","author":"L Liljeroos","year":"2015","unstructured":"Liljeroos, L., Malito, E., Ferlenghi, I. & Bottomley, M. J. Structural and computational biology in the design of immunogenic vaccine antigens. J. Immunol. Res. 2015, 156241 (2015).","journal-title":"J. Immunol. Res."},{"key":"2827_CR43","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.3390\/ijms160613106","volume":"16","author":"E Malito","year":"2015","unstructured":"Malito, E., Carfi, A. & Bottomley, M. J. Protein crystallography in vaccine research and development. Int J. Mol. Sci. 16, 13106\u201313140 (2015).","journal-title":"Int J. Mol. Sci."},{"key":"2827_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","volume":"213","author":"R Rappuoli","year":"2016","unstructured":"Rappuoli, R., Bottomley, M. J., D\u2019Oro, U., Finco, O. & De Gregorio, E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J. Exp. Med. 213, 469\u2013481 (2016).","journal-title":"J. Exp. Med."},{"key":"2827_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13376","volume":"7","author":"YA Yeung","year":"2016","unstructured":"Yeung, Y. A. et al. Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire. Nat. Commun. 7, 13376 (2016).","journal-title":"Nat. Commun."},{"key":"2827_CR46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbapap.2011.12.007","volume":"1824","author":"T Ramaraj","year":"2012","unstructured":"Ramaraj, T., Angel, T., Dratz, E. A., Jesaitis, A. J. & Mumey, B. Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. Biochim. Biophys. Acta 1824, 520\u2013532 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"2827_CR47","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1021\/bi000054l","volume":"39","author":"Y Li","year":"2000","unstructured":"Li, Y., Li, H., Smith-Gill, S. J. & Mariuzza, R. A. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). Biochemistry 39, 6296\u20136309 (2000).","journal-title":"Biochemistry"},{"key":"2827_CR48","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1546293","volume":"255","author":"JM Rini","year":"1992","unstructured":"Rini, J. M., Schulze-Gahmen, U. & Wilson, I. A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255, 959\u2013965 (1992).","journal-title":"Science"},{"key":"2827_CR49","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jmb.2008.01.093","volume":"377","author":"S Birtalan","year":"2008","unstructured":"Birtalan, S. et al. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J. Mol. Biol. 377, 1518\u20131528 (2008).","journal-title":"J. Mol. Biol."},{"key":"2827_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1128\/CVI.00474-15","volume":"22","author":"R Rossi","year":"2015","unstructured":"Rossi, R., Beernink, P. T., Giuntini, S. & Granoff, D. M. Susceptibility of meningococcal strains responsible for two serogroup B outbreaks on U.S. University Campuses to serum bactericidal activity elicited by the MenB-4C vaccine. Clin. Vaccine Immunol. 22, 1227\u20131234 (2015).","journal-title":"Clin. Vaccine Immunol."},{"key":"2827_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","volume":"61","author":"A Sorman","year":"2014","unstructured":"Sorman, A., Zhang, L., Ding, Z. & Heyman, B. How antibodies use complement to regulate antibody responses. Mol. Immunol. 61, 79\u201388 (2014).","journal-title":"Mol. Immunol."},{"key":"2827_CR52","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/CVI.00193-16","volume":"23","author":"S Giuntini","year":"2016","unstructured":"Giuntini, S. et al. Human IgG1, IgG3, and IgG3 hinge-truncated mutants show different protection capabilities against meningococci depending on the target antigen and epitope specificity. Clin. Vaccine Immunol. 23, 698\u2013706 (2016).","journal-title":"Clin. Vaccine Immunol."},{"key":"2827_CR53","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1073\/pnas.1213737110","volume":"110","author":"Y Wine","year":"2013","unstructured":"Wine, Y. et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proc. Natl Acad. Sci. USA 110, 2993\u20132998 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2827_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TG Battye","year":"2011","unstructured":"Battye, T. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D. Biol. Crystallogr. 67, 271\u2013281 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"2827_CR56","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini, M. et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252\u2013W258 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2827_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr."},{"key":"2827_CR58","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D. Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR59","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, N.","year":"1994","unstructured":"Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR62","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"2827_CR63","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1107\/S0907444904026460","volume":"D60","author":"E Krissinel","year":"2004","unstructured":"Krissinel E. and Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimension. Acta Crystallogr. D. Biol. Crystallogr. D60, 2256\u20132268 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2827_CR64","unstructured":"The PyMOL Molecular Graphics System, Version 1.8. (Schrodinger, LLC, 2015)"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02827-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:56:06Z","timestamp":1671540966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-02827-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"22 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.-S., L.S., E.F., M.P., and M.J.B. were employees of the GSK group of companies at the time of the study. M.J.B. and M.P. report ownership of GSK shares and\/or restricted GSK shares. M.J.B., P.T.B., and M.P. are inventors named on patents and patent applications relating to meningococcal group B vaccines. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}